Brigatinib in patients with ALK-positive advanced non-small-cell lung cancer pretreated with sequential ALK inhibitors: A multicentric real-world study (BRIGALK study)
Titel:
Brigatinib in patients with ALK-positive advanced non-small-cell lung cancer pretreated with sequential ALK inhibitors: A multicentric real-world study (BRIGALK study)
Auteur:
Descourt, Renaud Perol, Maurice Rousseau-Bussac, Gaëlle Planchard, David Mennecier, Bertrand Wislez, Marie Cortot, Alexis Guisier, Florian Galland, Loïck Dô, Pascal Schott, Roland Dansin, Eric Arrondeau, Jennifer Auliac, Jean-Bernard Chouaid, Christos